Xuebijing injection reduces COVID-19 patients’ mortality as influenced by the neutrophil to lymphocyte platelet ratio
NLPR is the most reliable inflammatory marker for predicting prognosis among individuals with COVID-19, and can accurately identify individuals who may benefit from Xuebijing injection. Please cite this article as: Liao M, Zhang LT, Bai LJ, Wang RY, Liu Y, Han J, Liu LH, Qi BL. Xuebijing injection reduces COVID-19 patients mortality as influenced by the neutrophil to lymphocyte platelet ratio. J Integr Med. 2025; 23(3): 282-288.
Authors
- Li-hua Liu
- Rui-yun Wang
- Man Liao (ORCID: https://orcid.org/0000-0002-1276-3158)
- Lijuan Bai (ORCID: https://orcid.org/0000-0001-9450-4581)
- Benling Qi (ORCID: https://orcid.org/0000-0003-3149-5707)
- Yun Liu (ORCID: https://orcid.org/0000-0001-7761-309X)
- Liting Zhang (ORCID: https://orcid.org/0000-0003-3007-1507)
- Jing Han (ORCID: https://orcid.org/0000-0003-0048-2241)
Institutions
- Wuhan Union Hospital (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Journal of Integrative Medicine
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.joim.2025.04.002
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05